Head-to-head comparisons of medication uses, side effects, warnings, and more.
Stelara (ustekinumab)
Rinvoq (upadacitinib)
Stelara (ustekinumab)
Rinvoq (upadacitinib)
Summary of Stelara vs. Rinvoq
Summary for IL-12 and IL-23 antagonist
Prescription only
Stelara (ustekinumab) is an injectable medication used to treat autoimmune conditions like psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. As an interleukin antagonist, it works by blocking certain proteins that cause inflammation in your body, which helps reduce swelling and ease symptoms. You get it as an injection, either under your skin or through a vein, depending on your condition. Common side effects include common cold symptoms, headache, and feeling tired. This medication also has many biosimilars available.
Summary for JAK inhibitor
Prescription only
Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor. It's used to treat certain inflammatory conditions, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and eczema (atopic dermatitis). But it's not a first-choice option and typically only prescribed when other treatments haven't worked well. Rinvoq (upadacitinib) is taken by mouth, usually once daily. It's available as an extended-release tablet (Rinvoq) and an oral solution (Rinvoq LQ), but the two formulations aren't interchangeable. Side effects include a higher risk of infections, acne, and nausea.
Indications of Stelara vs. Rinvoq
Indications for
•Moderate-to-severe plaque psoriasis (Ps) - adults and children 6 years and older